Search Results

Sarah Cannon Research Institute announced a collaboration with Tennessee Cancer Specialists, an independent, private practice oncology group, based in Knoxville, Tenn.

Sarah Cannon Research Institute announced that it will highlight its latest research insights through more than 145 presentations at the 2024 American Society of Clinical Oncology Annual Meeting from Friday, May 31 – Tuesday, June 4 in Chicago, Ill.

Sarah Cannon Research Institute announced that more than 80 abstracts and presentations have been selected for inclusion at the 65th American Society of Hematology Annual Meeting & Exposition.

Caris Life Sciences® announced that Sarah Cannon Research Institute, one of the world’s leading oncology research organizations conducting community-based clinical trials, has joined the Caris Precision Oncology Alliance™.

HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s leading healthcare providers, today announced that the Sarah Cannon Cancer Institute (SCCI) of HCA Healthcare has successfully established an integrated management process that safely transitioned more than 75% of HCA Healthcare’s CAR T-cell therapy patients into an outpatient setting for monitoring.

Sarah Cannon Research Institute announced that its network of research leaders have been selected to deliver insights through more than 135 abstracts and presentations at the 2023 American Society of Clinical Oncology Annual Meeting June 2-6, 2023.

Mirati Therapeutics, Inc.® and Sarah Cannon Research Institute announced a strategic partnership aimed at increasing diversity in clinical study recruitment practices.

Sarah Cannon Research Institute announced a collaboration with AstraZeneca, a global, science-led biopharmaceutical company, aimed at advancing innovative technology and operational synergies to enhance the delivery of oncology clinical trials.